Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.
about
Hepatitis B immune globulin for preventing hepatitis B recurrence after liver transplantationManagement of HBV Infection in Liver Transplantation PatientsChange of strategies and future perspectives against hepatitis B virus recurrence after liver transplantationLiver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxisProphylaxis and treatment of hepatitis B recurrence after liver transplantation in the antiviral era.Hepatitis B in transplantation.A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002.Hepatitis B immune globulin: product information and nursing implications.Chronic hepatitis B: current and future treatment options.Prevention of recurrent hepatitis B post-liver transplantation.Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B.Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analoguesPrevention of hepatitis B virus recurrence after liver transplantation.High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.Prophylaxis of hepatitis B infection in solid organ transplant recipients.Hepatitis B immunoglobulin in preventing reinfection following liver transplantation.Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation.Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation.Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees.Human polyclonal anti-hepatitis B surface antigen immunoglobulin reduces the frequency of acute rejection after liver transplantation for chronic hepatitis B.Safety and efficacy of subcutaneous hepatitis B immunoglobulin after liver transplantation: an open single-arm prospective study.Combination of HBIG and lamivudine-resistant mutations: a formula for trouble?Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma.The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation.Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant.Favorable outcome of liver transplantation despite a high hepatitis B virus replication: beyond the limits?Dilemma of recurrence of hepatitis B infection after liver transplantation.Hepatitis B (HB) immunoglobulin plus HB vaccine for intrauterine HB virus infection.Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management.Management of chronic hepatitis B before and after liver transplantation.Molecular Variants of Hepatitis B Surface Antigen (HBsAg)
P2860
Q24198922-778946FB-D160-47B9-9A17-A4ECFEB2F779Q24529103-2CE11C44-D4C4-4126-8621-AFE911CD5C0FQ26784241-BD354F49-FC37-4867-A6B1-C4A5FA8DC891Q28348802-CCD23E41-6D39-4E1D-9A5B-4A592FFE5561Q33207885-7A8A0D4F-0CFC-490F-929F-E839024C0ED3Q34294933-00571F11-5058-44D2-B2A3-FA355548EE84Q34499694-4D8E1528-2C82-4AB6-9268-5478246068A2Q34547734-2DF0B53E-CFE2-4743-91AD-4AD0C2E87A66Q34687438-942830C9-4A8A-4E02-9895-633E450A2A57Q34936261-3FE59C20-7D2A-4187-BD46-386A8A2E90CAQ36028324-5C52C672-916E-4E8F-A830-C8F880C1A856Q36442537-96CEC946-54FB-4BD8-9735-782CF25C6372Q36652077-DCCDB085-4996-476F-9D58-CD7583566DC7Q36747829-F23F5AFA-9AA0-473A-8221-026D4D850B72Q36886518-7E489E2B-FE85-44E3-A59E-E1E42AD23F74Q37432104-E7782C21-DCFC-4162-ACEF-F721BE0CEE7FQ37495757-6534CF94-3057-4A57-BA9F-4B09B939B874Q37905782-DD713A3B-F4D9-46E4-90B3-DABE74D22F8FQ38177252-4155484D-67CA-4DD9-87A3-80D06F5A9599Q38218762-079CBC59-834D-4B2E-ADB4-A3F66F83BAF5Q40302269-481984F4-7E89-4356-AA52-07F502631EFDQ43131712-C41F88F5-ADBE-4261-81C3-4D9DF5E6E86DQ43493343-6C4EE865-F401-42F2-BF0A-3A34838BD9CDQ43756998-8A1E72A3-1352-4276-9511-1385CA011DE9Q43791510-9D6A1D9E-F2FA-461B-968C-131070205277Q44243304-7E492CC6-5520-4C6C-905A-317285479034Q44425133-342F7E34-8413-495C-B2E6-84E3F60EBD3BQ44461497-6D97286A-BC3F-45F4-9F5A-A3FAD66326EFQ45413279-C25EE1D8-B273-4AAC-A60C-9A3C92A73910Q50600644-0DEC4793-6127-4D3F-9AE9-F316F49AAAA0Q51802512-2FB37833-00D6-4F72-A8F8-6A6F7AB52910Q52620441-5E57EE2E-CC2E-4503-8DCD-88CEA50A454FQ54266050-49844797-5110-422D-8900-92EB19454C38Q58808840-5C0CCF06-0761-4547-964D-6253472537F8
P2860
Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Improved clinical outcomes wit ...... re using passive immunization.
@ast
Improved clinical outcomes wit ...... re using passive immunization.
@en
type
label
Improved clinical outcomes wit ...... re using passive immunization.
@ast
Improved clinical outcomes wit ...... re using passive immunization.
@en
prefLabel
Improved clinical outcomes wit ...... re using passive immunization.
@ast
Improved clinical outcomes wit ...... re using passive immunization.
@en
P2093
P1433
P1476
Improved clinical outcomes wit ...... ure using passive immunization
@en
P2093
A Abdulkareem
A McNamara
B L Shephard
C C McCullough
C W Houlgrave
M J Gaffey
R W McGory
S H Caldwell
T L Pruett
P304
P356
10.1097/00000658-199806000-00007
P407
P577
1998-06-01T00:00:00Z